Making Measurements Meaningful Brian J. Zikmund-Fisher, PhD - - PowerPoint PPT Presentation

making measurements meaningful
SMART_READER_LITE
LIVE PREVIEW

Making Measurements Meaningful Brian J. Zikmund-Fisher, PhD - - PowerPoint PPT Presentation

Making Measurements Meaningful Brian J. Zikmund-Fisher, PhD University of Michigan Department of Health Behavior & Health Education Department of Internal Medicine Center for Bioethics & Social Sciences in Medicine Health Informatics


slide-1
SLIDE 1

Making Measurements Meaningful

Brian J. Zikmund-Fisher, PhD

University of Michigan

Department of Health Behavior & Health Education Department of Internal Medicine Center for Bioethics & Social Sciences in Medicine Health Informatics Program @bzikmundfisher

slide-2
SLIDE 2

Assumptions In Science Communication

Assumption: People Lack Information

(The Deficit Model)

Assumed Solution: Give them more!

slide-3
SLIDE 3

Barriers

Language Literacy Numeracy Emotionality of Health Situations Volume of Relevant Information

slide-4
SLIDE 4

More ≠ Better!

slide-5
SLIDE 5

Evaluability

slide-6
SLIDE 6

Good or Bad?

Amend B. Welcome to Jasorassic Park, 1998, p.36.

slide-7
SLIDE 7

Good or Bad?

Amend B. Welcome to Jasorassic Park, 1998, p.36.

slide-8
SLIDE 8

Evaluability

  • f Risk Information
slide-9
SLIDE 9

Imagine Robert

slide-10
SLIDE 10

Imagine Robert

Your 10-year risk of cardiovascular disease is:

11.22%

slide-11
SLIDE 11

“Am I at high risk,

  • r not?”
slide-12
SLIDE 12

Evaluability

  • f Laboratory

Test Results

slide-13
SLIDE 13

Can Patients Use This?

slide-14
SLIDE 14

What Is Out of Range?

slide-15
SLIDE 15

What Is Out of Range?

slide-16
SLIDE 16

“Am I at high risk,

  • r not?”
slide-17
SLIDE 17

Evaluability

  • f Exposure

Information

slide-18
SLIDE 18

Buying a Home…

Radon: 6 pCi/L

slide-19
SLIDE 19

Drinking Water…

Lead: 7 ppb

slide-20
SLIDE 20

“Am I at high risk,

  • r not?”
slide-21
SLIDE 21

Problem #1: Numbers

slide-22
SLIDE 22

Problem #2: Lack of Meaning

slide-23
SLIDE 23

So now what?

What can we do to help?

slide-24
SLIDE 24

Step 1: Visual information

slide-25
SLIDE 25

Robert’s Risk

Created at iconarray.com

slide-26
SLIDE 26
slide-27
SLIDE 27

Tables

Zikmund-Fisher BJ, et al. Graphics help patients distinguish between urgent and non-urgent deviations in laboratory test results. Journal of the American Medical Informatics Association 2017;24(3):520-528.

slide-28
SLIDE 28

Table vs. Number Line

Zikmund-Fisher BJ, et al. Graphics help patients distinguish between urgent and non-urgent deviations in laboratory test results. Journal of the American Medical Informatics Association 2017;24(3):520-528.

slide-29
SLIDE 29

Lines with More Meaning

Zikmund-Fisher BJ, et al. Graphics help patients distinguish between urgent and non-urgent deviations in laboratory test results. Journal of the American Medical Informatics Association 2017;24(3):520-528.

slide-30
SLIDE 30

Near-Normal Results vs. Extreme Results

Near-Normal Extreme

Zikmund-Fisher BJ, et al. Graphics help patients distinguish between urgent and non-urgent deviations in laboratory test results. Journal of the American Medical Informatics Association 2017;24(3):520-528.

slide-31
SLIDE 31

% with No Difference in Perceived Urgency

Platelets

(135 vs 25 x109/L)

ALT

(80 vs 360 U/L)

Creatinine

(2.2 vs 3.4 mg/dl)

Table 26.5 56.3 43.7 Simple Line 17.5 21.3 27.7 Block Line 19.0 20.2 28.7 Gradient Line 15.8 14.8 24.0

Zikmund-Fisher BJ, et al. Graphics help patients distinguish between urgent and non-urgent deviations in laboratory test results. Journal of the American Medical Informatics Association 2017;24(3):520-528.

slide-32
SLIDE 32

Step 2: Gist-full information

slide-33
SLIDE 33

Fuzzy Trace Theory

(Brainerd and Reyna, 1995)

Verbatim memory Gist

vs

slide-34
SLIDE 34

Fuzzy Trace Theory

(Brainerd and Reyna, 1995)

Verbatim memory Gist

What the heck is “gist”?

vs

slide-35
SLIDE 35
slide-36
SLIDE 36

Know Your “Commander’s Intent”

Heath & Heath, Made to Stick, 2007

slide-37
SLIDE 37

Cancer Screening Test Decisions

slide-38
SLIDE 38

Colorectal Cancer Screening

slide-39
SLIDE 39

Colorectal Cancer Screening

… at age 50

slide-40
SLIDE 40

Colorectal Cancer Screening

… at age 50 … vs. at age 75

(with multiple comorbidities)

slide-41
SLIDE 41

Benefits vs. Harms

Image from study materials for “Promoting Veteran-Centered Colorectal Cancer Screening” (I01 HX001278-01); SD Saini, PI.

slide-42
SLIDE 42

Gist Processing

Image from study materials for “Promoting Veteran-Centered Colorectal Cancer Screening” (I01 HX001278-01); SD Saini, PI.

slide-43
SLIDE 43

Setting the Context in Visual Displays

slide-44
SLIDE 44

Hemoglobin A1c

Unpublished graphic from 1 R01 HS021681, BJ Zikmund-Fisher, Principal Investigator.

slide-45
SLIDE 45

Same (?!?) Result

Unpublished graphic from 1 R01 HS021681, BJ Zikmund-Fisher, Principal Investigator.

slide-46
SLIDE 46

Scale Matters

Unpublished graphics from 1 R01 HS021681, BJ Zikmund-Fisher, Principal Investigator.

slide-47
SLIDE 47

Test Results for Diagnosed Patients

slide-48
SLIDE 48

Goals for Test Results

Scherer AM, Witteman HO, Solomon J, Fagerlin A, Exe NL, Zikmund-Fisher BJ. Improving understanding of test results by substituting (not adding) goal ranges. Poster presentation to the Society for Medical Decision Making, Vancouver, BC, Canada, October 23, 2016.

slide-49
SLIDE 49

Goals for Test Results

Scherer AM, Witteman HO, Solomon J, Fagerlin A, Exe NL, Zikmund-Fisher BJ. Improving understanding of test results by substituting (not adding) goal ranges. Poster presentation to the Society for Medical Decision Making, Vancouver, BC, Canada, October 23, 2016.

slide-50
SLIDE 50

Goals for Test Results

Scherer AM, Witteman HO, Solomon J, Fagerlin A, Exe NL, Zikmund-Fisher BJ. Improving understanding of test results by substituting (not adding) goal ranges. Poster presentation to the Society for Medical Decision Making, Vancouver, BC, Canada, October 23, 2016.

slide-51
SLIDE 51

Goals for Test Results

Scherer AM, Witteman HO, Solomon J, Fagerlin A, Exe NL, Zikmund-Fisher BJ. Improving understanding of test results by substituting (not adding) goal ranges. Poster presentation to the Society for Medical Decision Making, Vancouver, BC, Canada, October 23, 2016.

slide-52
SLIDE 52

Test Results for Monitoring

slide-53
SLIDE 53

Harms

Alanine Aminotransferase (ALT):

80 IU/L

Standard Range: 10-40

slide-54
SLIDE 54

Showing the Possible Range

Zikmund-Fisher BJ, Scherer AM, Witteman HO, Solomon J, Exe NL, Fagerlin A. Providing harm anchors in visual displays of test results can mitigate patient perceptions of urgency about near-normal values. Journal of Medical Internet Research, 2018.

slide-55
SLIDE 55

Harm Anchors

Zikmund-Fisher BJ, Scherer AM, Witteman HO, Solomon J, Exe NL, Fagerlin A. Providing harm anchors in visual displays of test results can mitigate patient perceptions of urgency about near-normal values. Journal of Medical Internet Research, 2018.

slide-56
SLIDE 56

Harm Anchors

“Many doctors are not concerned until here”

Zikmund-Fisher BJ, Scherer AM, Witteman HO, Solomon J, Exe NL, Fagerlin A. Providing harm anchors in visual displays of test results can mitigate patient perceptions of urgency about near-normal values. Journal of Medical Internet Research, 2018.

slide-57
SLIDE 57

Increased Sensitivity with Harm Anchors

1 2 3 4 5 6

Near Value Extreme Value

Perceived Alarm Simple Harm Anchor

Zikmund-Fisher BJ, Scherer AM, Witteman HO, Solomon J, Exe NL, Fagerlin A. Providing harm anchors in visual displays of test results can mitigate patient perceptions of urgency about near-normal values. Journal of Medical Internet Research, 2018.

slide-58
SLIDE 58

One Last Example

slide-59
SLIDE 59

7 7.1 7.2 7.3 7.4 7.5 7.6 7.7 5 10 15 20

Hemoglobin A1c

Percent Months

slide-60
SLIDE 60

7 7.1 7.2 7.3 7.4 7.5 7.6 7.7 5 10 15 20

Hemoglobin A1c

Percent Months

Central Message: Varies

slide-61
SLIDE 61

7 7.1 7.2 7.3 7.4 7.5 7.6 7.7 10 20

Months Percent

slide-62
SLIDE 62

7 7.1 7.2 7.3 7.4 7.5 7.6 7.7 10 20 4 6 8 10 12 10 20

=

?

Months Months Percent Percent

slide-63
SLIDE 63

7 7.1 7.2 7.3 7.4 7.5 7.6 7.7 10 20 4 6 8 10 12 10 20 2 4 6 8 10 20

=

?

Months Months Months Percent Percent Percent

slide-64
SLIDE 64

7 7.1 7.2 7.3 7.4 7.5 7.6 7.7 10 20 4 6 8 10 12 10 20 2 4 6 8 10 20

=

?

Months Months Months Percent Percent Percent

Varies!

slide-65
SLIDE 65

7 7.1 7.2 7.3 7.4 7.5 7.6 7.7 10 20 4 6 8 10 12 10 20 2 4 6 8 10 20

=

?

Months Months Months Percent Percent Percent

Varies! Stable!

slide-66
SLIDE 66

7 7.1 7.2 7.3 7.4 7.5 7.6 7.7 10 20 4 6 8 10 12 10 20 2 4 6 8 10 20

=

?

Months Months Months Percent Percent Percent

Varies! Stable! High!

slide-67
SLIDE 67

7 7.1 7.2 7.3 7.4 7.5 7.6 7.7 10 20 4 6 8 10 12 10 20 2 4 6 8 10 20

=

? Scaled to data variations

Months Months Months Percent Percent Percent

Varies! Stable! High!

slide-68
SLIDE 68

7 7.1 7.2 7.3 7.4 7.5 7.6 7.7 10 20 4 6 8 10 12 10 20 2 4 6 8 10 20

=

? Scaled to data variations Scaled to population variations

Months Months Months Percent Percent Percent

Varies! Stable! High!

slide-69
SLIDE 69

7 7.1 7.2 7.3 7.4 7.5 7.6 7.7 10 20 4 6 8 10 12 10 20 2 4 6 8 10 20

=

? Scaled to data variations Scaled to population variations Scaled to zero

Months Months Months Percent Percent Percent

Varies! Stable! High!

slide-70
SLIDE 70

4 5 6 7 8 9 10 11 12 5 10 15 20

Good

  • r

Bad?

slide-71
SLIDE 71

4 5 6 7 8 9 10 11 12 5 10 15 20

Standard Range

Good

  • r

Bad?

slide-72
SLIDE 72

4 5 6 7 8 9 10 11 12 5 10 15 20

Good

  • r

Bad?

Target Range for Patients with Type 2 Diabetes

slide-73
SLIDE 73

My Commander’s Intent

slide-74
SLIDE 74

“We need to design for the way people ARE, not the way we wish they were”

  • Holly O. Witteman
slide-75
SLIDE 75

People only process or remember

  • ne thing
slide-76
SLIDE 76

You can’t change this fact!

slide-77
SLIDE 77

BUT…

slide-78
SLIDE 78

BUT… You get to choose!

slide-79
SLIDE 79

Use context to create ONE message based on THEIR needs

slide-80
SLIDE 80

Thank You!

bzikmund@umich.edu @bzikmundfisher